Web Summit Vancouver and Rio de Janeiro
- Asees Kaur
- May 13
- 2 min read
This year, VoxCell BioInnovation proudly participated as a GROWTH startup at both Web Summit Rio and the first-ever Web Summit Vancouver, two of the world’s leading tech conferences, drawing thousands of entrepreneurs, investors, and global changemakers.
At both events, we showcased our 3D vascularized cancer tissue models, joined the Startup Showcase, and delivered talks on how human-relevant models can reshape drug development. In Vancouver, we were especially proud to be featured as a key life sciences startup representing BC’s innovation ecosystem, in partnership with Life Sciences BC.
The highlight? Winning the $10K Pitch: BC’s Startup All-Stars, a live competition hosted by New Ventures BC and Innovate BC. Among 12 standout ventures, VoxCell claimed the $10,000 grand prize, recognized for advancing ethical, effective cancer drug testing technologies.
We also took the stage for several presentations, including a powerful talk by our CEO, Dr. Karolina Valente, titled “The Bloodline of Drug Discovery,” underscoring the need for vascularized human-like tissues in modern drug screening.
About Web Summit
Web Summit is a global technology conference series that brings together the world’s most ambitious startups, investors, and thought leaders. In 2025, the event made its Vancouver debut, succeeding Collision as North America’s fastest-growing tech summit. With over 70,000+ attendees and 5,000+ startups annually across Lisbon, Rio, Qatar, and now Vancouver, Web Summit continues to be a launchpad for global innovation and bold ideas.
About VoxCell BioInnovation
VoxCell BioInnovation is a leading provider of next-generation in vitro models, powered by our 3D bioprinted, vascularized tissue technology. Our ready-to-perfuse models closely replicate human biology with in vivo–like microvascular networks, enabling nutrient and oxygen delivery, systemic drug distribution, and more predictive therapeutic responses. VoxCell’s end-to-end solution offers researchers and pharmaceutical companies a scalable, ethical alternative to animal testing. Our mission is to reduce reliance on animal models, accelerate preclinical development, and advance more effective therapies for patients.
Want to learn more or collaborate?
Visit our website, connect with us on LinkedIn, or email us at hello@voxcellbio.com.
